29 March 2022 - Today, the U.S. FDA authorised a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 ...
23 March 2022 - Moderna today announced positive interim data from the Phase 2/3 KidCOVE study of the Moderna COVID-19 ...
17 March 2022 - Moderna today announced that it has submitted a request to the U.S. FDA for an amendment ...
15 March 2022 - The U.S. has made tremendous progress in our fight against COVID-19. ...
15 March 2022 - Submission based on real-world safety and efficacy data from Israel. ...
9 March 2022 - During the COVID-19 pandemic, patients have asked courts to compel hospitals to administer unproven therapies, including ivermectin. ...
6 March 2022 - Company says it has resolved manufacturing problems that led to earlier delays; FDA is reviewing shot’s authorisation ...
19 February 2022 - The agency has begun reviewing data that could lead to clearing a second booster dose of ...
11 February 2022 - Pfizer and BioNTech today announced plans to extend their rolling submission to the U.S. FDA seeking ...
11 February 2022 - Bebtelovimab neutralises Omicron as demonstrated by pseudovirus and authentic virus data ...
1 February 2022 - Companies plan to submit additional data on a third 3 µg dose in this age group in ...
31 January 2022 - Second Veru drug under development to receive FDA fast track designation this month. ...
31 January 2022 - NVX-CoV2373 demonstrated overall efficacy of ~90% in PREVENT-19 clinical trial conducted during the emergence of variant ...
31 January 2022 - Today, the U.S. FDA approved a second COVID-19 vaccine. ...
27 January 2022 - Pfizer wants to intervene in a Texas federal lawsuit seeking information from the U.S. FDA used ...